LONG-ACTING ERYTHROPOETIN EFFICACY IN THE TREATMENT OF NEPHROGENIC ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT A PREDIALYSIS STAGE

by Yu S Milovanov, L Yu Milovanova
Published 2012-06-01

Difficulties in correcting hyperphosphatemia in patients with chronic renal failure. A place of noncalcium-containing phosphate-binding drugs

by Yu S Milovanov, V V Fomin, L Yu Milovanova
Published 2016-06-01

Cardioprotective effect of erythropoietin preparations in patients with chronic renal failure

by A Yu Nikolaev, V M Ermolenko, L Yu Milovanova, Yu S Milovanov
Published 2004-09-01

Intradialysis hypotension: causes and sequelae

by L Yu Milovanova, A Yu Nikolaev, V V Safonov, Yu S Milovanov
Published 2003-06-01

Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor...

by L Yu Milovanova, L V Kozlovskaya, Yu S Milovanov, I N Bobkova, I A Dobrosmyslov
Published 2010-06-01

The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chron...

by N A Mukhin, Yu S Milovanov, L V Kozlovskaya, I A Dobrosmyslov, L Yu Milovanova
Published 2016-04-01

HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems

by S Yu Milovanova, L V Lysenko (Kozlovskaya), L Yu Milovanova, N N Mrykhin, A V Russkih, N A Muchin
Published 2018-06-01

The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys

by Yuriy Sergeevich Milovanov, Lidiya Vladimirovna Kozlovskaya, Lyudmila Yur'evna Milovanova, Yu S Milovanov, L V Kozlovskaya, L Yu Milovanova
Published 2011-06-01

Quality of life of chronic kidney disease patients on renal replacement therapy

by Yu S Milovanov, I A Dobrosmyslov, S Yu Milovanova, M V Taranova, L Yu Milovanova, V V Fomin, V V Kozlov
Published 2018-06-01

Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis

by N. V. Chebotareva, S. V. Gulyaev, T. V. Androsova, E. N. Popova, D. V. Gurova, P. I. Novikov, L. Yu. Milovanova, S. V. Moiseev
Published 2020-06-01

Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD...

by L Yu Milovanova, I A Dobrosmyslov, Yu S Milovanov, V V Fomin, M V Taranova, V V Kozlov, S Yu Milovanova, E I Kozevnikova
Published 2018-06-01

The role of balanced low-protein diet in inhibition of progression of predialysis chronic disease of the kidneys in systemic diseases

by Yuriy Sergeevich Milovanov, Lidiya Vladimirovna Lysenko, Lyudmila Yur'evna Milovanova, Igor' Aleksandrovich Dobrosmyslov, Yu S Milovanov, L V Lysenko, L Yu Milovanova, I A Dobrosmyslov
Published 2009-08-01

Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney di...

by L Yu Milovanova, Yu S Milovanov, D V Kudryavtseva, M M Markina, S Yu Milovanova, L V Kozlovskaya, M V Lebedeva, V D Beketov, S V Moiseev, N A Mukhin, V V Fomin, A A Svistunov
Published 2015-06-01